COMBINATION OF RAF-265 AND AN ACTIVATOR OF AMPK FOR USE IN THE TREATMENT OF A PROLIFERATIVE DISEASE
摘要
<p>Provided are compositions and uses of the benzimidazole pyridyl ether {1-methyl-5-[2-(5-tri-fluoromethyl-1H-imidazol-2-yl)-pyridin-4-yloxy]-1H-benzoimidazol-2-yl}-(4-trifluoromethylphenyl)-amine and pharmaceutically acceptable salts thereof in combination with an activator of AMPK (AMP-activated protein kinase) for the treatment of proliferative diseases.</p>
